AMN vs BIO · rev $2.98B vs rev $2.58B
AMN Healthcare Services Inc (AMN) versus BIO (BIO) — a side-by-side from cached financials, not a winner call.
AMN Healthcare Services Inc (AMN) is a medical care facilities company listed on US.
BIO (BIO) common stock.
Latest reported AMN revenue for 2024-12-31 was $2.98B. Net income was -$147.0M. Revenue was down 21.3% from 2023-12-31 to 2024-12-31. AMN currently screens at market cap $1.23B.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
AMN currently screens at market cap $1.23B. BIO currently screens at market cap $0.
Not investment advice. Open the AMN and BIO stock pages for the full models.
Not investment advice.